Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study
- PMID: 10914621
Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study
Abstract
Objective: The aim of this study was to delineate the use of hormone replacement therapy (HRT) among women who were born between December 2, 1935, and December 1, 1945, and living in the Lund area of southern Sweden and to analyze factors that contribute to the acceptance and continuation of HRT.
Methods: All women received a generic questionnaire pertaining to demographic background, lifestyle, health behavior, and climacteric symptoms and underwent a personal interview. An interim analysis was carried out on 3,900 women. We mailed a hormone questionnaire to the women who were using HRT (n = 1,875). This hormone questionnaire covered, for example, menopausal status, complaints, and alterations in and efficacy of HRT use, as well as the reasons for discontinuing HRT use.
Results: A total of 1,415 (76%) women answered the hormone questionnaire. Forty-eight percent were HRT ever users, and 32% were current users. Mean duration of HRT use was 47 months. The most common incentives for HRT use were alleviation of menopausal symptoms (72%) and prevention of bone loss (50%) and/or cardiovascular disease (31%). Forty-seven percent of HRT users reported that they had changed regimens at least once. HRT users had higher education, full-time work, and a higher consumption of alcohol but less consumption of cigarettes. They reported higher frequencies of climacteric symptoms, past histories of premenstrual syndrome, use of oral contraceptives, and hysterectomy. They also had a higher consumption of healthcare resources. A total of 177 women withdrew from therapy. The most common reasons for discontinuation of HRT were weight gain, anxiety of cancer, bleeding, breast tenderness, and emotional problems. Compared with current users, past users had less positive as well as fewer negative effects of HRT. Several variables contributed to compliance, including education, full-time work, regular exercise, low frequency of persistent climacteric symptoms, and alteration of regimens.
Conclusion: Education, working conditions, lifestyle, interest in prevention, and severity of the climacteric symptoms are determinants for both acceptance of and compliance with HRT.
Similar articles
-
Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.Obstet Gynecol. 1997 Aug;90(2):269-77. doi: 10.1016/S0029-7844(97)00264-0. Obstet Gynecol. 1997. PMID: 9241307
-
Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women.Maturitas. 2005 Nov-Dec;52(3-4):306-18. doi: 10.1016/j.maturitas.2005.05.005. Epub 2005 Jun 20. Maturitas. 2005. PMID: 15967603
-
Factors associated with climacteric symptoms and the use of hormone replacement therapy.Acta Obstet Gynecol Scand. 2000 Apr;79(4):286-92. Acta Obstet Gynecol Scand. 2000. PMID: 10746844
-
Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.Taiwan J Obstet Gynecol. 2007 Jun;46(2):127-34. doi: 10.1016/S1028-4559(07)60006-0. Taiwan J Obstet Gynecol. 2007. PMID: 17638620 Review.
-
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.Climacteric. 2001 Sep;4(3):181-93. Climacteric. 2001. PMID: 11588941 Review.
Cited by
-
Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a prospective cohort study.CMAJ. 2014 Mar 18;186(5):338-44. doi: 10.1503/cmaj.131064. Epub 2014 Jan 27. CMAJ. 2014. PMID: 24468693 Free PMC article.
-
Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy.Menopause. 2012 Apr;19(4):471-5. doi: 10.1097/gme.0b013e3182333847. Menopause. 2012. PMID: 22027945 Free PMC article. Clinical Trial.
-
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.BMC Womens Health. 2007 Oct 18;7:19. doi: 10.1186/1472-6874-7-19. BMC Womens Health. 2007. PMID: 17945013 Free PMC article.
-
The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - experience from the EPHT trial.BMC Womens Health. 2009 Jun 8;9:16. doi: 10.1186/1472-6874-9-16. BMC Womens Health. 2009. PMID: 19505307 Free PMC article. Clinical Trial.
-
Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome.Ayu. 2012 Oct;33(4):511-6. doi: 10.4103/0974-8520.110529. Ayu. 2012. PMID: 23723668 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous